TEAM Technologies acquires Duke Empirical to expand advanced medical device capabilities

TEAM Technologies acquires Duke Empirical: ©Murrstock - stock.adobe.com

TEAM Technologies, a portfolio company of Arlington Capital Partners, has acquired Duke Empirical, a California-based manufacturer specializing in advanced interventional cardiovascular devices, the investment firm announced.

The acquisition strengthens TEAM Tech’s position as a full-service outsourced manufacturer for complex Class II and III medical devices. Duke Empirical, headquartered in Morgan Hill, Calif., is known for its innovative catheters and minimally invasive delivery systems—capabilities that will complement TEAM Tech’s existing portfolio and expand its capacity to serve top-tier healthcare and MedTech OEM clients, according to the company.

“When we began our partnership with Arlington, we knew we had an opportunity to accelerate our growth and expand our offerings to best serve our clients,” said Marshall White, president and CEO of TEAM Tech. “Duke adds complementary capabilities and greater capacity to our already robust portfolio of full-service medical device manufacturing solutions.”

TEAM Tech provides end-to-end outsourced design and manufacturing services to health care companies, helping streamline supply chains and reduce lead times for mission-critical products. Arlington Capital Partners said the deal aligns with its investment strategy to support companies delivering complex solutions in regulated markets.

“The addition of Duke expands TEAM Tech’s ability to serve leading health care and medtech OEMs in the fastest growing segments of the medical device market,” said Matt Altman, managing partner at Arlington. “It enhances its capabilities to develop and manufacture highly advanced devices that support the delivery of life saving medical procedures.”

Sector outlook: Growth and innovation in outsourced medical device manufacturing

The acquisition comes amid significant momentum in the outsourced medical device manufacturing industry, driven by rising demand for minimally invasive procedures, supply chain optimization, and increasing regulatory complexity.

As medical device companies look to bring products to market faster and more efficiently, many are turning to end-to-end partners like TEAM Tech that offer integrated design, development, and production services. Outsourcing enables firms to focus on innovation and clinical outcomes while navigating tight timelines and compliance hurdles.

Cardiovascular devices, in particular, are a rapidly expanding segment. Innovations in catheter-based treatments, stents, and delivery systems are revolutionizing care for conditions like heart failure, coronary artery disease, and arrhythmias. With Duke’s expertise in polymer extrusion and interventional technologies, TEAM Tech is positioning itself at the heart of this growth.

Private equity interest in this sector has also surged. Firms like Arlington Capital Partners are investing in platforms that can scale quickly and serve as strategic partners for medical device OEMs. These investments support consolidation in the fragmented contract manufacturing space, where specialized capabilities—such as Class III device manufacturing or sterile packaging—are increasingly critical.

Overall, the market outlook remains strong. Analysts project the global medical device outsourcing market will surpass $100 billion by 2032, driven by both technological advances and increasing demand for high-quality care at lower cost. Companies that can offer turnkey solutions and navigate the regulatory landscape are poised to lead this transformation.